Omnicare Announces Extension of the Early Tender Deadline for the Tender Offer and Consent Solicitation of Its Outstanding 6.75% Senior Subordinated Notes Due 2013

Omnicare, Inc. (NYSE: OCR), announced today that is has extended the Early Tender Deadline of the tender offer and consent solicitation for its outstanding 6.75% Senior Subordinated Notes due 2013 (the "2013 Notes") to 5:00 p.m., New York City time, on May 18, 2010, unless further extended. Holders who tender (and do not validly withdraw) their Notes and validly deliver (and do not validly revoke) their consents prior to the Early Tender Deadline will be entitled to receive the total consideration of $1,033.75, which includes an early tender payment of $30.00 per $1,000 principal amount of Notes. Holders who tender (and do not validly withdraw) their Notes after the Early Tender Deadline will be eligible to receive the total consideration minus the early tender payment. Holders who tender (and do not validly withdraw) their Notes will receive the accrued and unpaid interest on such Notes through, but not including, the applicable payment date in connection with the Tender Offer.

As of 5:00 p.m. New York City time on Friday, May 14, 2010, tenders and consents in respect of approximately $207 million aggregate principal amount of the 2013 Notes were validly delivered (and not withdrawn) in the Tender Offer.

The Tender Offer and Consent Solicitation is being made upon the terms and subject to the conditions set forth in the Offer to Purchase and Consent Solicitation Statement, dated May 3, 2010, as amended or supplemented, and a related Letter of Transmittal and consent (together, the "Offer Documents”). Except for the extension of the Early Tender Deadline, all other terms and conditions of the Offer to Purchase and Letter of Transmittal remain unchanged.

The Tender Offer is scheduled to expire at 11:59 p.m., New York City time, on May 28, 2010, unless terminated or extended. Notes may be withdrawn at any time prior to the Early Tender Deadline, but not thereafter.

J.P. Morgan Securities Inc. and SunTrust Robinson Humphrey, Inc. are acting as dealer managers for the Tender Offer. The information agent and tender agent for the tender offer is D.F. King & Co., Inc. Questions regarding the Tender Offer may be directed to J.P. Morgan Securities Inc. at telephone number (800) 245-8812 (toll free) and (212) 270-3994 (call collect), or SunTrust Robinson Humphrey, Inc. at telephone number (404) 926-5051 (call collect). Requests for copies of the Offer Documents may be directed to D.F. King & Co., Inc., telephone number (888) 887-0082 (toll free) and (212) 269-5550 (call collect).

This announcement is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell with respect to the Notes nor is this announcement an offer to sell or solicitation of an offer to purchase new securities. The Tender Offer is being made solely by means of the Offer Documents, which more fully set forth and govern the terms and conditions of the Tender Offer. The Offer Documents contain important information and should be read carefully before any decision is made with respect to the Tender Offer.

About Omnicare, Inc.

Omnicare, Inc. (NYSE: OCR), a Fortune 500 company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly. Omnicare serves residents in long-term care facilities, chronic care and other setting comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada. Omnicare is the largest U.S. provider of professional pharmacy , related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings. Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals. Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in 32 countries worldwide.

In addition to historical information, this press release contains certain statements that constitute "forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of management’s views and assumptions regarding business performance as of the time the statements are made, and management does not undertake any obligation to update these statements. These forward-looking statements include, but are not limited to, all statements regarding the intent, belief or current expectations regarding the matters discussed or incorporated by reference in this document (including statements as to "beliefs,” "expectations,” "anticipations,” "intentions” or similar words) and all statements which are not statements of historical fact. These forward-looking statements, together with other statements that are not historical, involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those stated. Such risks, uncertainties, contingencies and other factors, many of which are beyond the control of the Company, include, but are not limited to: overall economic, financial, political and business conditions; and other risks and uncertainties described in the Offer to Purchase and Consent Solicitation Statement and in the Company’s reports and filings with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as otherwise required by law, the Company does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.